DECLARATION OF INTEREST
KBF is a consultant to Genentech, Optovue, Zeiss, Novartis, Bayer and Heidelberg Engineering, he receives research support from Genentech/Roche. RDM is consultant to Heidelberg Engineering, Novartis and Allergan; she receives research support from Genentech, Roche and Thrombogenics. The other authors have no relevant financial conflicts.